1. Home
  2. NCEL vs OBAI Comparison

NCEL vs OBAI Comparison

Compare NCEL & OBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$3.49

Market Cap

17.2M

Sector

Health Care

ML Signal

N/A

Logo TG-17 Inc. Common Stock

OBAI

TG-17 Inc. Common Stock

N/A

Current Price

$0.88

Market Cap

20.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
NCEL
OBAI
Founded
2008
2017
Country
Switzerland
United States
Employees
4
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
17.2M
20.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NCEL
OBAI
Price
$3.49
$0.88
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
30.5K
24.3M
Earning Date
05-12-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.83
$0.43
52 Week High
$5.12
$19.95

Technical Indicators

Market Signals
Indicator
NCEL
OBAI
Relative Strength Index (RSI) 54.99 57.73
Support Level $2.95 $0.45
Resistance Level $3.62 $1.66
Average True Range (ATR) 0.24 0.16
MACD 0.01 0.06
Stochastic Oscillator 100.00 35.86

Price Performance

Historical Comparison
NCEL
OBAI

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.

About OBAI TG-17 Inc. Common Stock

Our Bond Inc is a personal security service through its AI-powered Preventive Personal Security platform. It is trusted by corporations, cities, and universities, and has already supported many security service requests, emergencies and life-saving interventions. The cloud-based Bond Preventative Personal Security Platform provides users with remote protective services via phone app (using its Bond Preventative Personal Security Platform) and with 24/7 support from its Personal Security Agents, who are in Bond Command Centers and can respond rapidly. It offers distinct services through its phone app (the Bond App) and fully automated Bond Command Centers. Geographically, the company operates in Israel, France, and United States. It derives maximum revenue from United States.

Share on Social Networks: